mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |